In 2023, Dr. Hardy completed his PhD candidature as an international collaboration between the University of Newcastle (Australia, his home institution), and the Medical University of Graz (Austria), conducting research on campus at both institutions throughout. He then obtained a fellowship at St John’s College Oxford, funding an independent research program until 2027. The work he is conducting under this fellowship is investigating vascular, immune and fibrotic responses in both the early onset of cardiovascular diseases, and the later wound healing stages. One branch of his work is utilizing translational models to trial the therapeutic potential of stimulating angiogenesis and lymphangiogenesis after myocardial infarction. The other is identifying novel therapeutic targets involved in the early development of coronary microvascular disease, which often precedes large coronary artery disease and myocardial infarction.